NURIX THERAPEUTICS, INC.
About NURIX THERAPEUTICS, INC.
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines for cancer, inflammatory conditions and other diseases. The company leverages expertise in E3 ligases and its proprietary DELigase discovery platform, which incorporates DNA-encoded libraries, to develop oral small molecule therapies that modulate cellular protein levels. Its pipeline includes candidates such as bexobrutideg (NX-5948) for chronic lymphocytic leukemia and autoimmune indications, as well as NX-2127 and NX-1607. Nurix is headquartered in Brisbane, California and trades on NASDAQ under the ticker NRIX.
- 🔗 Nurix Completes $250.0 Million Follow-On Offering | Baird
- 🔗 Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering | Nurix Therapeutics, Inc.
- 🔗 Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock | Nurix Therapeutics, Inc.
- 🔗 Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares | Nurix Therapeutics, Inc.
- 🔗 S-1
Investors
Key highlights
- Completed $250 million follow-on public offering in 2024 to fund clinical development of bexobrutideg (NX-5948) and pipeline expansion.
- Pipeline targets targeted protein degradation for CLL and autoimmune indications using the DELigase platform.
- Incorporated in Delaware in 2009 and previously known as Nurix, Inc. before going public on NASDAQ.
- Public equity transactions included participation from multiple healthcare-dedicated funds.
- Originally filed S-1 for IPO and has transitioned to a publicly traded clinical-stage company.
Ask StreetZero about NURIX THERAPEUTICS, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account